Yang, Z., Peng, Y., Guo, W., Xu, J., Li, L., Tian, H., . . . He, J. (2021). PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer. Thorac Cancer.
Chicago Style CitationYang, Zhenlin, et al. "PD‐L1 and CD47 Co‐expression Predicts Survival and Enlightens Future Dual‐targeting Immunotherapy in Non‐small Cell Lung Cancer." Thorac Cancer 2021.
Cita MLAYang, Zhenlin, et al. "PD‐L1 and CD47 Co‐expression Predicts Survival and Enlightens Future Dual‐targeting Immunotherapy in Non‐small Cell Lung Cancer." Thorac Cancer 2021.
Atenció: Aquestes cites poden no estar 100% correctes.